FDA Drug Application (020616) for KADIAN by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number020616
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameKADIAN
Active IngredientMORPHINE SULFATE

Active IngredientCount
List of drugs with Active Ingredient MORPHINE SULFATE11


Back to FDA Applications sponsored by ALLERGAN SALES LLC